اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 5 (Sep and Oct 2023 2023) ::
Koomesh 2023, 25(5): 28-28 Back to browse issues page
Gliclazide-loaded Solid Lipid Nanoparticles: Development, Physicochemical characterization and in-situ single-pass intestinal permeability evaluation
Ziba Islambulchilar , Parvin Zakeri-Milani , Hadi Valizadeh , Akbar Saei
Abstract:   (314 Views)
Introduction: Gliclazide, a sulfonylurea specifically used for the treatment of non-insulin-dependent diabetes mellitus, exhibits low oral bioavailability due to its poor aqueous solubility and first pass metabolism. The aim of the present study is to develop, prepare and evaluate the physicochemical characteristics of gliclazide loaded solid lipid nanoparticles (SLN) and to determine and to compare the intestinal permeability of gliclazide loaded SLNs and free gliclazide using the single pass intestinal perfusion (SPIP) method in rat.
Methods and Materials: Solid lipid nanoparticles (SLN) were designed and prepared using different proportions of formulation components. Physicochemical characteristics of formulations including droplet size, poly dispersity index and zeta potential, encapsulation efficiency, drug loading and drug release were evaluated. SPIP technique was applied to determine intestinal permeability. Both free gliclazide and gliclazide loaded nanoparticles were perfused through a cannulated segment of rat jejunum. Outlet perfusates were collected every 10 min to 90 min and were analyzed by HPLC. Permeability coefficients (Peff) were calculated and compared.
Results: The optimized SLN formulation consists of 300 mg stearyl alcohol, 330 mg Brij 58 and 70 mg Transcutol P. Droplet size and PDI of optimized formulation were 81 nm and 0.13 respectively. The encapsulation efficiency of optimized SLN was 87.5 % and it has released more than 90 % of its drug content during 20 hours. The effective intestinal permeability of free gliclazide and gliclazide loaded SLNs were 1.34 × 10 -4 and 2.78 × 10-4 cm/s. Therefore loading in solid lipid nanoparticles led to a significant increase in intestinal permeability of gliclazide.
Conclusion: Solid lipid nanoparticles could be considered as promising tools for oral delivery of gliclazide according to appropriate physicochemical properties and observed increase in its intestinal permeability which could consequently enhance its oral bioavailability. 

 
Keywords: Gliclazide, Solid lipid nanoparticle, Permeability, SPIP
Full-Text [PDF 263 kb]   (56 Downloads)    
Type of Study: Research | Subject: General
Received: 2023/09/16 | Accepted: 2023/08/23 | Published: 2023/08/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Islambulchilar Z, Zakeri-Milani P, Valizadeh H, Saei A. Gliclazide-loaded Solid Lipid Nanoparticles: Development, Physicochemical characterization and in-situ single-pass intestinal permeability evaluation. Koomesh 2023; 25 (5) :28-28
URL: http://koomeshjournal.semums.ac.ir/article-1-8069-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 5 (Sep and Oct 2023 2023) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645